Categories AlphaGraphs, Earnings, Other Industries

What’s in the offing for Village Farms (VFF) Q2 earnings?

Village Farms International (NASDAQ: VFF), a Canada-based vegetable producer that entered into cannabis space in 2017, will be reporting its second quarter 2019 results on Monday, August 12, 2019, after the market close. The company will host a conference call to discuss its second quarter results next day morning.

Read: Village Farms swing to profit in Q2 2019

After rallying 10% on Thursday, VFF stock swung between a positive and negative zone today and ended up 5% when the market closed.

Village Farms International (VFF) to report Q2 2019 earnings results on Monday

When Village Farms reports its June quarter results, investors would watch out the production updates from Pure Sunfarms, the company’s  50% owned joint venture with Emerald Health and Village Fields Hemp, a joint venture formed with Nature Crisp, for the cultivation of high-cannabidiol (CBD) hemp and CBD extraction in multiple states throughout the US.

For the first quarter ended March 31, 2019, Village Farms reported net income of $7.65 million or $0.15 per diluted share compared to a loss of $1.14 million or $0.03 per diluted share in the quarter ended March 31, 2018. The last reported quarter’s net income included a gain on disposal assets of $13.57 million.

Sales for the March quarter increased 8% to $31.89 million. Sales including Pure Sunfarms’ contribution of $5.4 million increased to $37.3 million.

Related: What you need to know before buying Village Farms International stock

The company’s Canadian peak vegetable growing production is in the summer months, with no production during the winter season. As a result, Village Farms historically reports higher sales in the second and third quarters than in the first and fourth quarters.

In July, Village Farms announced that Pure Sunfarms achieved full run-rate production of 75,000 kilograms of dried cannabis annually at its 1.1 million square foot Delta 3 greenhouse facility in Delta, B.C. Pure Sunfarms expects its in-house extraction capabilities to be operational this year.

Pure Sunfarms also expects to complete its first harvest at the Delta 2 facility by mid-2020, ramp to full run-rate annual production by the fourth quarter of 2020, and operate at full production of 75,000 throughout 2021.

Related: Aphria stock jumps after reporting better-than-expected Q4 results

Village Farms also announced that its program for outdoor cultivation of high-cannabidiol (CBD) hemp and CBD extraction is progressing on plan. The Company’s joint venture for hemp production and processing in the Eastern U.S., Village Fields Hemp, expects initial sales of hemp biomass to commence in the fourth quarter of 2019.

“We are closely monitoring developments as the Texas Department of Agriculture proceeds towards establishing a licensing and regulatory framework for hemp cultivation and processing and continue to expect our Permian Basin greenhouse to be ready to begin hemp production as
soon as we are permitted to do so under Texas legislation,” said CEO Michael DeGiglio.

cannabis stocks market cap comparison; Canopy Growth, Aurora Cannabis, GW pharmaceuticals, Cronos Group, Tilray, Aphria, Hexo, Village Farms

Recently, Village Farms has transitioned from foreign private issuer status to domestic issuer status in the US since more than 50% of the company’s common shares were directly or indirectly owned of record by shareholders domiciled in the United States on June 28, 2019. As a result of becoming a U.S. domestic issuer, the company will be subject to SEC reporting requirements applicable to a U.S. domestic company, beginning on January 1, 2020.

Since Village Farms started trading on NASDAQ on February 21 this year, the stock had rallied 31% so far.

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top